Ireland - English - HPRA (Health Products Regulatory Authority)

bausch + lomb ireland limited - tetracaine hydrochloride - eye drops, solution - local anesthetics; tetracaine

United States - English - NLM (National Library of Medicine)

bausch & lomb americas inc. - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride ophthalmic solution, usp 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. tetracaine hydrochloride ophthalmic solution, usp 0.5% should not be used in patients with a history of hypersensitivity to any component of this preparation. risk summary there are no adequate and well-controlled studies with tetracaine hydrochloride ophthalmic solution, usp 0.5% in pregnant women. animal developmental and reproductive toxicity studies with tetracaine hydrochloride have not been reported in the published literature. risk summary there are no data to assess whether tetracaine hydrochloride ophthalmic solution, usp 0.5% is excreted in human milk or to assess its effects on milk production/excretion. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for tetracaine hydrochloride ophthalmic solution, usp 0.5% and any potential adverse effects on the breastfed child from tetracaine hydroc

United States - English - NLM (National Library of Medicine)

bausch & lomb incorporated - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride ophthalmic solution, usp 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. tetracaine hydrochloride ophthalmic solution, usp 0.5% should not be used in patients with a history of hypersensitivity to any component of this preparation. risk summary there are no adequate and well-controlled studies with tetracaine hydrochloride ophthalmic solution, usp 0.5% in pregnant women. animal developmental and reproductive toxicity studies with tetracaine hydrochloride have not been reported in the published literature. risk summary there are no data to assess whether tetracaine hydrochloride ophthalmic solution, usp 0.5% is excreted in human milk or to assess its effects on milk production/excretion. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for tetracaine hydrochloride ophthalmic solution, usp 0.5% and any potential adverse effects on the breastfed child from tetracaine hydroc

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - tetracaine hydrochloride - eye drops solution - 0.5 %w/v - tetracaine

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - tetracaine hydrochloride - eye drops solution - 1.0 %w/v - tetracaine

United States - English - NLM (National Library of Medicine)

st. renatus - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv), oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - tetracaine hydrochloride 30 mg in 1 ml - kovanaze tm is indicated for regional anesthesia when performing a restorative procedure on teeth 4-13 and a-j in adults and children who weigh 40 kg or more. kovanaze is contraindicated in patients with a history of allergy to or intolerance of tetracaine, benzyl alcohol, other ester local anesthetics, p -aminobenzoic acid (paba), oxymetazoline, or any other component of the product [see warnings and precautions ( 5.5)] . risk summary limited published data on tetracaine use in pregnant women are not sufficient to inform any risks. published epidemiologic studies of nasal oxymetazoline used as a decongestant during pregnancy do not identify a consistent association with any specific malformation or pattern of malformations [see data] . in animal reproduction and development studies, oxymetazoline given subcutaneously to rats during the period of organogenesis caused structural abnormalities at a dose approximately 7.6 times the exposure

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bausch & lomb uk ltd - tetracaine hydrochloride - eye drops - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bausch & lomb uk ltd - tetracaine hydrochloride - eye drops - 10mg/1ml

United States - English - NLM (National Library of Medicine)

ocusoft, inc. - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride 25 mg in 5 ml - for procedures in which a rapid and short acting topical ophthalmic anesthetic is indicated such as in tonometry, gonioscopy, removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, suture removal from the cornea or conjunctiva, other short corneal and conjunctival procedures. should not be used by the patient without physician supervision, or in those persons showing hypersensitivity to any component of this preparation. safety and effectiveness in children have not been established.

United States - English - NLM (National Library of Medicine)

ocusoft, inc. - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride 3 mg in 0.6 ml - for procedures in which a rapid and short acting topical ophthalmic anesthetic is indicated such as in tonometry, gonioscopy, removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, suture removal from the cornea or conjunctiva, other short  corneal and conjunctival procedures.   should not be used by the patient without physician supervision, or in those persons showing hypersensitivity to any component of this preparation. safety and effectiveness in children have not been established.